Ethnopharmacological relevance: There is no evidence in the literature that substantiates the safety of Campomanesia xanthocarpa (Berg.) use during pregnancy. Materials and methods: Thirty three female rats were randomly assigned to three groups. One group of animals received the Campomanesia xanthocarpa extract via gavage at a dose of 26.3 mg/kg/day from 6 to 15 days of pregnancy (organogenic period, T1) and another group received the same extract throughout the gestational period (from the 1st to the 20th day of pregnancy, T2). Control groups received distilled water. Euthanasia was done on 20th day, when the liver, kidney, spleen ovaries, fetuses and their respective placentas were removed. Implantations, reabsorptions, live and dead fetuses were recorded. Results and conclusions: Campomanesia xanthocarpa, in these experimental conditions, did not disturb the reproductive function of female rats and did not interrupt the progress of the embryofetal development. Moreover, our results provide further evidence that the Campomanesia xanthocarpa treatment reduces reabsorption sites, increases placenta weight and the number of live fetuses and may therefore have therapeutic applications.
Introduction
Campomanesia xanthocarpa Berg. (Myrtaceae), popularly known as "guavirova" is present in the Southern region of Brazil and is likewise found in Argentina, Paraguay, and Uruguay (Lorenzi, 1992) . Campomanesia xanthocarpa leaves and stem bark are traditionally employed as a folk medicine to regulate the intestinal flux, for the treatment of cystitis, urethritis, dysentery and as an anti-inflammatory agent (D'ávila, 1990; Barroso, 1991; Alice et al., 1995) . A recent study demonstrated that Campomanesia xanthocarpa extract has antiplatelet, antithrombotic, and fibrinolytic activities in mice and it may be effective in preventing thrombus formation through several pathways (Klafke et al., 2012) . Additionally, Klafke et al. (2010) showed that Campomanesia xanthocarpa has reduced the blood cholesterol levels in hypercholesterolemic patients and may therefore have therapeutic applications (Klafke et al., 2010) .
Based on the knowledge that toxicity often occurs during pregnancy and may have different effects on embryo development depending on the conceptus phase and the maternal conditions (Wilson 1977; Mason and Kang, 1989; Oliveira et al., 2009) and that Campomanesia xanthocarpa is widely used in folk medicine (Alice et al., 1995; Dickel et al., 2007) , the aim of the present investigation was to evaluate the effect of Campomanesia xanthocarpa on pregnant rats exposed in two windows of treatment: throughout the gestational period (from the 1st to the 20th day of pregnancy) or during the organogenic period (from 6th to 15th day of pregnancy). The Campomanesia xanthocarpa single dose used in this experiment was based on the average consumption by the population since this plant is indiscriminately used during gestation and lactation, particularly by women of lower socioeconomic status. specimen was identified by Maria do Carmo Vieira and deposited (No. 6123) in the herbarium of the Federal University of Grande Dourados (UFGD). The fresh leaves (200 g) were extracted in water at 95-100 1C (10 L) by 10 min and left to macerate for 24 h in room temperature. After this period, the extract was filtered and concentrated under vacuum and lyophilizer. The yield of the crude extract was 16.7%. During the treatment, the extract was dissolved in distilled water.
Materials and methods

Preparation of extract
Animals
The females were mated with males and the gestational day 0 (GD0) was determined if there were spermatozoa in the vagina. These animals were housed in a standard animal facility under controlled temperature (22 1C) and photoperiod (12 h light, 12 h dark) with access to water and rodent food ad libitum. All procedures and protocols followed approved guidelines for the ethical treatment of animals, according to the Ethics Committee in Animal Experimentation from the Federal University of Mato Grosso do Sul (Protocol # 107/2006).
Experimental procedure
The mated females were randomly assigned to two experimental groups and exposed to Campomanesia xanthocarpa during organogenic period (from 6th to 15th day of pregnancy, T1) or throughout the gestational period (from the 1st to the 20th day of pregnancy, T2). The dose used in this experiment corresponded to that used as a folk medicine (D'ávila, 1990; Alice et al., 1995) . The females of the Campomanesia xanthocarpa exposed group received 26.3 mg/kg/day of the extract suspended in 0.5 mL in distilled water, via gavage, during the window of the treatment (T1 and T2). The control group received only the vehicle (0.5 mL/kg).
The females were weighed on days 1, 6, 15 and 20 of pregnancy to determine maternal toxicity. On day 20 of pregnancy, the females were sacrificed. Laparotomy was performed and uterine horns were removed. The number of implants, resorptions, and dead and live fetuses were then recorded. The ovaries were also observed and the corpora lutea were counted. The rate of preimplantation loss was calculated as: no. of corpora lutea−no. of implantations Â 100/no. of corpora lutea. Postimplantation loss rate was calculated as: no. of implantation−no. of live fetuses Â 100/no. of implantations. The fetuses were weighted and examined for macroscopic external malformations. Some of them were fixed in Bouin's solution for visceral examination. The maternal kidney, spleen and liver were also weighted.
Statistical analysis
Values are expressed as mean 7SEM and data were analyzed using the one-way ANOVA followed by the Tukey post-test using Graph-Pad Prism (version 5; Graph-Pad Software Inc., San Diego, CA, USA). The significance level was set at p o0.05.
Results and discussion
In none of the experimental groups, maternal deaths, locomotor alterations, diarrhea or piloerection, that are clinical signals of maternal toxicity, were observed. The maternal body weight in both experimental groups investigated (T1 and T2) was similar. The Campomanesia xanthocarpa treatment did not affect the absolute weight of the spleen, liver and kidney (Table 1) . Reduction or increases in the weight of these organs suggest toxicity (Queiroz et al., 2012) . In addition, this study confirms earlier findings that Campomanesia xanthocarpa did not produce toxic symptoms in mice in doses up to 5 g/kg (Markman et al., 2004) . Although Campomanesia xanthocarpa is used in folk medicine for weight loss, the present investigation did not confirm it in pregnant rats. Table 1 summarizes the maternal and fetal parameters. A significant increase was observed in the placental weights of the Campomanesia xanthocarpa exposed animals (T1 and T2), in comparison with control. Moreover, it should be emphasized that placental weight has a significant role in fetal growth in terms of weight, body length, and cord length (Lo et al., 2002) . Corroborating these findings, our results showed an increased fetal weight in both groups treated with Campomanesia xanthocarpa. The number of live fetuses were also significantly increased in the Campomanesia xanthocarpa exposed animals. Examination of live fetuses for external and visceral anomalies did not show a significant effect of the treatment.
The reproductive indices of implantation, reabsorption and preand postimplantation losses are shown in Table 2 . The implantation index, considered an indicator of success of the blastocyst implantation in the endometrium (Tyl and Marr, 2006) , was similar between the control and treated groups. However, the number of reabsorptions which are indicative of abnormal postimplantation development (Kalter, 1980) were decreased in Campomanesia xanthocarpa exposed animals. The effect of the Campomanesia xanthocarpa treatment on the period before embryo implantation was evaluated by determining the rate of preimplantation loss. This rate is a parameter used to establish a correlation between the number of released ova, which after fertilization, manage to implant in the uterus (Almeida and Lemonica., 2000) . In comparison with control, the preimplantation loss in T2 group presented tendency to be lower, although it was not statistically significant. The treatment during the organogenic period was intended to evaluate possible embryotoxic or embryolethal effects. The rate of postimplantation loss was not significant in both treated groups, which indicates that this window of treatment did not cause embryolethality.
Conclusion
As far as we know, our study is the first report in the literature which evaluates the effects of Campomanesia xanthocarpa in female rats during pregnancy. We can assume that Campomanesia xanthocarpa, in these experimental conditions, did not disturb the reproductive function of female rats and did not interrupt the progress of the embryofetal development. Moreover, our results provide further evidence that the Campomanesia xanthocarpa treatment reduces reabsorption sites, increases placenta weight and the number of live fetuses and may therefore have therapeutic applications.
